Comparative Analysis of da Vinci-Assisted and Laparoscopic Duodenal Switch Bariatric Surgical Procedures

September 28, 2023 updated by: Intuitive Surgical

A Comparative Analysis of da Vinci-Assisted and Laparoscopic Duodenal Switch (DS) Bariatric Surgical Procedures

To compare the safety and effectiveness of robotic-assisted Duodenal-Switch Bariatric Surgical Procedures (including Biliopancreatic Diversion-Duodenal-Switch/BPD-DS, Single Anastomosis- Duodeno Ileal Bypass with Sleeve/SADI-S, and One Anastomosis Duodenal Switch/OADS) with laparoscopic approaches using real world data (RWD) from the Premier Healthcare Database (PHD).

Study Overview

Detailed Description

To compare the safety and effectiveness of robotic-assisted Duodenal-Switch Bariatric Surgical Procedures (including Biliopancreatic Diversion-Duodenal-Switch/BPD-DS, Single Anastomosis- Duodeno Ileal Bypass with Sleeve/SADI-S, and One Anastomosis Duodenal Switch/OADS) with laparoscopic approaches using real world data (RWD) from the Premier Healthcare Database (PHD). The study endpoints include:

Safety Related Outcomes

  1. Intraoperative Complication Rates
  2. Transfusion Rates
  3. 30-Day Post-Operative Complication Rates*
  4. 30-Day Readmission Rates*
  5. 30-Day Reoperation Rates*
  6. 30-Day Mortality*

Effectiveness Related Outcomes

  1. Conversion Rate to Open Surgery
  2. Operative Time
  3. Length of Hospital Stay

Study Type

Observational

Enrollment (Actual)

1878

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • California
      • Sunnyvale, California, United States, 94086
        • Intuitive Surgical

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

N/A

Sampling Method

Probability Sample

Study Population

All patients meeting the inclusion/exclusion criteria iwho underwent DS Bariatric Surgical Procedures between January 1, 2016 and December 31, 2020 will be included. Acute and 30-day follow up data will be included in this analysis.

Description

Inclusion Criteria-

  1. Patients who are ≥ 18 years old and had a primary laparoscopic or robotic-assisted bariatric surgery procedure with a duodenal switch (DS) defined herein as BPD-DS, SADI-S, or OADS; and,
  2. Met one of the below qualifications:

    • Body mass index (BMI) > 40 kg/m2 OR
    • BMI > 35 kg/m2 and had one of the following obesity-related co-morbidities such as type II diabetes mellitus, hypertension, sleep apnea and other respiratory disorders, non-alcoholic fatty liver disease, osteoarthritis, lipid abnormalities, gastrointestinal disorders, or heart disease according to the US Centers of Medicare & Medicaid Services (CMS) criteria for the use of bariatric surgery in adults

Exclusion Criteria-

  • Were diagnosed with cancer; or
  • Underwent an outpatient DS bariatric surgical procedure; or
  • Underwent an emergent DS bariatric surgical procedure; or
  • Underwent a DS procedure concomitant to a different primary procedure (i.e., colon resection)
  • Underwent a revisional DS bariatric surgical procedure (i.e., patient had a prior bariatric procedure within three (3) years of the DS procedure)
  • Have missing operating room (OR) time data (i.e., incomplete billing record)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Other
  • Time Perspectives: Retrospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
robotic-assisted

Robotic-assisted cases converted to open will be part of the robotic cohort.

Comparison of the following safety and effectiveness related surgical outcomes across robotic-assisted and laparoscopic cohorts:

Safety Related Outcomes

  1. Intraoperative Complication Rates
  2. Transfusion Rates
  3. 30-Day Post-Operative Complication Rates
  4. 30-Day Readmission Rates
  5. 30-Day Reoperation Rates
  6. 30-Day Mortality

Effectiveness Related Outcomes

  1. Conversion Rate to Open Surgery
  2. Operative Time
  3. Length of Hospital Stay
da Vinci Surgical System
laparoscopic

Laparoscopic cases converted to open will be part of the laparoscopic cohort.

Comparison of the following safety and effectiveness related surgical outcomes across robotic-assisted and laparoscopic cohorts:

Safety Related Outcomes

  1. Intraoperative Complication Rates
  2. Transfusion Rates
  3. 30-Day Post-Operative Complication Rates
  4. 30-Day Readmission Rates
  5. 30-Day Reoperation Rates
  6. 30-Day Mortality

Effectiveness Related Outcomes

  1. Conversion Rate to Open Surgery
  2. Operative Time
  3. Length of Hospital Stay
laparoscopic bariatric surgery

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Intraoperative Complication Rates (Safety)
Time Frame: Intraoperative
Incidence of complications occuring intraoperatively
Intraoperative
Transfusions (Safety)
Time Frame: perioperative
Transfusion Rates Rate of transfusion that occur intraoperatively and postoperatively
perioperative
30-Day Post-Operative Complication Rates (Safety)
Time Frame: Intraoperative to 30-days (from the date of surgery upto 30-days)
Incidence of complications that occur after surgery to 30-days
Intraoperative to 30-days (from the date of surgery upto 30-days)
30-Day Readmission Rates (Safety)
Time Frame: Upto 30 days
Incidence of readmission that occur after discharge
Upto 30 days
30-Day Reoperation Rates (Safety)
Time Frame: upto 30 days following the documented date of the surgery
Incidence of reoperations that occur after till 30 days
upto 30 days following the documented date of the surgery
30-day Mortality Rate (Safety)
Time Frame: Intra-operative to 30-days
Incidence of mortality until 30 days
Intra-operative to 30-days
Conversion rate to open surgery (Effectiveness)
Time Frame: Intraoperative
Incidence of conversion to open that occur intraoperatively
Intraoperative
Operative Time (Effectiveness)
Time Frame: Intraoperative
Amount of time it takes to complete the procedure (in min)
Intraoperative
Length of hospital Stay (Effectiveness)
Time Frame: perioperative
Number of days participant is in the hospital
perioperative

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Usha L Kreaden, Intuitive Surgical

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 1, 2022

Primary Completion (Actual)

September 22, 2022

Study Completion (Actual)

September 22, 2022

Study Registration Dates

First Submitted

September 20, 2022

First Submitted That Met QC Criteria

October 7, 2022

First Posted (Actual)

October 12, 2022

Study Record Updates

Last Update Posted (Actual)

September 29, 2023

Last Update Submitted That Met QC Criteria

September 28, 2023

Last Verified

September 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • Bariatric surgery

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

Yes

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe